Works matching IS 03125963 AND DT 2025 AND VI 64 AND IP 1
Results: 11
Relative Forgiveness of Different Allopurinol Implementation Patterns in People with Gout and their Impact on Clinical Outcomes: a Simulation Study: Relative Forgiveness of Different Allopurinol Implementation Patterns in People with Gout: M. White-Koning et al
- Published in:
- Clinical Pharmacokinetics, 2025, v. 64, n. 1, p. 93, doi. 10.1007/s40262-024-01467-z
- By:
- Publication type:
- Article
Population Pharmacokinetics of Epcoritamab Following Subcutaneous Administration in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma: PPK of Epcoritamab SC in R/R B-NHL: T. Li et al.
- Published in:
- Clinical Pharmacokinetics, 2025, v. 64, n. 1, p. 127, doi. 10.1007/s40262-024-01464-2
- By:
- Publication type:
- Article
Evaluation of the Effect of Risankizumab on the Pharmacokinetics of Cytochrome P450 Substrates in Patients with Moderately to Severely Active Ulcerative Colitis or Crohn's Disease: Effect of Risankizumab on the PK of CYP450 Substrates in Patients with UC or CD: R. D'Cunha et al
- Published in:
- Clinical Pharmacokinetics, 2025, v. 64, n. 1, p. 143, doi. 10.1007/s40262-024-01462-4
- By:
- Publication type:
- Article
Echinocandins Pharmacokinetics: A Comprehensive Review of Micafungin, Caspofungin, Anidulafungin, and Rezafungin Population Pharmacokinetic Models and Dose Optimization in Special Populations: Echinocandins Pharmacokinetics: A Comprehensive Review: M. Albanell-Fernández
- Published in:
- Clinical Pharmacokinetics, 2025, v. 64, n. 1, p. 27, doi. 10.1007/s40262-024-01461-5
- By:
- Publication type:
- Article
A Pooled Pharmacokinetic Analysis for Piperacillin/Tazobactam Across Different Patient Populations: From Premature Infants to the Elderly: A Pooled PK Analysis for Piperacillin/Tazobactam Across Different Patient Populations: D. Kong et al.
- Published in:
- Clinical Pharmacokinetics, 2025, v. 64, n. 1, p. 107, doi. 10.1007/s40262-024-01460-6
- By:
- Publication type:
- Article
A Review of Vancomycin, Gentamicin, and Amikacin Population Pharmacokinetic Models in Neonates and Infants: A PopPK Model Review of Neonatal Antibiotics: M. Albanell-Fernández et al.
- Published in:
- Clinical Pharmacokinetics, 2025, v. 64, n. 1, p. 1, doi. 10.1007/s40262-024-01459-z
- By:
- Publication type:
- Article
Correction: Population Pharmacokinetic Analysis of Tucatinib in Healthy Participants and Patients with Breast Cancer or Colorectal Cancer: PopPK Analysis of Tucatinib in Healthy Participants and Patients with BC or CRC: D. Zhang et al.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Static Versus Dynamic Model Predictions of Competitive Inhibitory Metabolic Drug–Drug Interactions via Cytochromes P450: One Step Forward and Two Steps Backwards: Static versus Dynamic Models to Predict DDIs via CYP: I. Tiryannik et al.
- Published in:
- Clinical Pharmacokinetics, 2025, v. 64, n. 1, p. 155, doi. 10.1007/s40262-024-01457-1
- By:
- Publication type:
- Article
Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis: Clinical Pharmacokinetics of Psilocin after Psilocybin Administration: M. E. Otto et al.
- Published in:
- Clinical Pharmacokinetics, 2025, v. 64, n. 1, p. 53, doi. 10.1007/s40262-024-01454-4
- By:
- Publication type:
- Article
Clinical Pharmacokinetics and Safety of Remdesivir in Phase I Participants with Varying Degrees of Renal Impairment: PK and Safety of Remdesivir in Renal Impairment: H. Zhang et al.
- Published in:
- Clinical Pharmacokinetics, 2025, v. 64, n. 1, p. 67, doi. 10.1007/s40262-024-01453-5
- By:
- Publication type:
- Article
Population Pharmacokinetic and Toxicity Analysis of High-Dose Methotrexate in Patients with Central Nervous System Lymphoma: Population PK and Toxicity Analysis of HD-MTX: A. Yin et al.
- Published in:
- Clinical Pharmacokinetics, 2025, v. 64, n. 1, p. 79, doi. 10.1007/s40262-024-01452-6
- By:
- Publication type:
- Article